(3S)-3-(beta-D-Glucopyranosyloxy)-5-({(2E)-3-[4-(beta-D-glucopyranosyloxy)-3,5-dimethoxyphenyl]-2-propen-1-yl}oxy)-3-methyl-5-oxopentanoic acid(CAS: 117278-74-7)

This compound is subject to various regulatory guidelines. Under GHS, it is classified based on its physical and chemical properties. For industrial and commercial use, it must comply with REACH regulations in the EU, which require manufacturers and importers to register substances above a certain tonnage. In the USA, FDA and EPA regulations may apply depending on its intended use, such as in pharmaceuticals or environmental applications.

There are several alternatives in synthesis, including using isomers or analogs. For example, (3R)-isomers or similar compounds with a similar structure can be used as alternatives. Common alternative reagents include different coupling agents or precursors that can produce similar functional groups, such as glycosyltransferases or other enzymatic methods.

The market and research trends for this compound are focused on its potential applications in pharmaceuticals, particularly in diabetes management and glycosylation studies. Research is also exploring its use in natural product chemistry and as a chiral building block in organic synthesis. Market trends suggest increasing demand due to its unique glycosylation properties and potential therapeutic benefits.

Waste containing this compound should be collected in appropriate containers and stored in a well-ventilated area. It should be disposed of by incineration or professional waste disposal services that comply with local regulations. Environmental protection precautions include ensuring no direct contact with skin or eyes and using appropriate personal protective equipment. Proper documentation and labeling are essential to ensure safe handling and disposal.